YSELTY

Serial Number 99161689
Registration 8058685
700

Registration Progress

Application Filed
Apr 29, 2025
Under Examination
Approved for Publication
Oct 21, 2025
Published for Opposition
Oct 21, 2025
Registered
Dec 9, 2025

Trademark Image

YSELTY

Basic Information

Serial Number
99161689
Registration Number
8058685
Filing Date
April 29, 2025
Registration Date
December 9, 2025
Published for Opposition
October 21, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 9, 2025
Registration
Registered
Classes
005

Rights Holder

Kissei Pharmaceutical Co., Ltd.

03
Address
19-48, Yoshino, Matsumoto-shi
Nagano 399-8710
JP

Ownership History

Kissei Pharmaceutical Co., Ltd.

Original Applicant
03
Nagano JP

Kissei Pharmaceutical Co., Ltd.

Owner at Publication
03
Nagano JP

Kissei Pharmaceutical Co., Ltd.

Original Registrant
03
Nagano JP

Legal Representation

Attorney
John M. Mueller

USPTO Deadlines

Next Deadline
2129 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20251209)
Due Date
December 09, 2031
Grace Period Ends
June 09, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

10 events
Date Code Type Description Documents
Dec 9, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 9, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 21, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 21, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 15, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 21, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 18, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 29, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 29, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 29, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for diagnostic purposes, treatment and prevention of endometriosis, uterine fibroids and other disorders of the reproductive system, of hormonally dependent conditions, and of inflammatory and immune system disorders

Classification

International Classes
005